Southern Research is a nonprofit, translational scientific research organization with an 80-year legacy of moving science through drug discovery, drug development and environmental health. This legacy includes helping shape modern cancer treatment practices by developing seven FDA-approved cancer drugs and co-creating a COVID-19 vaccine currently in clinical trials. These innovations are made possible because of our greatest assets, our people that move science every day at every level of Southern Research.
Location: United States, Alabama, Birmingham
Employees: 201-500
Phone: +1 205-581-2000
Total raised: $2.8M
Founded date: 1941
Investors 1
| Date | Name | Website |
| - | Venture fo... | venturefor... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 13.10.2019 | Grant | $2.8M | - |
Mentions in press and media 9
| Date | Title | Description |
| 25.02.2026 | Free genetic testing program aims to improve medical care across Alabama | An initiative aimed at improving medical care and addressing chronic disease is now underway in Alabama. Catalyst, a precision medicine program led by the Alabama nonprofit Southern Research in collaboration with Broad Clinical Labs at the ... |
| 03.02.2026 | Southern Research, Pathogenus Create Global Partnership | Southern Research and London-based Pathogenus Consulting have signed a three-year partnership that will allow both organizations to capitalize on growing research opportunities around the world. This press release features multimedia. View ... |
| 10.05.2024 | Winners of 2024 Alabama ORBIE Awards Announced By AlabamaCIO | Executives from Encompass Health, O'Neal Industries, McWane, Inc., Southern Veterinary Partners, Milo's Tea Company, Inc., & Southern Research recognized for their Achievements BIRMINGHAM, Ala., May 10, 2024 /PRNewswire-PRWeb/ -- Alabam... |
| 27.07.2021 | Tonix Pharmaceuticals Announces Agreement to Acquire Infectious Disease R&D Facility to Accelerate Development of Vaccines and Antiviral Drugs | R&D Facility in Frederick, MD is Expected to Provide Internal Capacity to Discover and Develop Vaccines and Antiviral Drugs Against COVID-19, its Variants and Other Infectious Diseases Facility, Currently Owned and Operated by Tonix Par... |
| 16.04.2020 | Covid-19 vaccine tracker updated to include GSK/Sanofi collaboration | By Jeff Craven Currently, there are no FDA-approved therapies or vaccines for SARS-CoV-2, the virus that causes Covid-19. The National Institute of Allergy and Infectious Diseases (NIAID) within the National Institutes... |
| 09.04.2020 | Covid-19 Tracker updates vaccine candidates | By Jeff Craven On March 11, the World Health Organization classified the Covid-19 outbreak as a pandemic. The disease has reached nearly every country, infecting hundreds of thousands of people and killing thousands. Curr... |
| 27.06.2016 | Inside a monkey lab, research gets fast-tracked in the ‘Zika room’ | MADISON, Wisc. — Walk into most macaque enclosures, and you might expect a ruckus: bird-like cooing if you’re bringing them food, or guttural barks if you aren’t. But these 13 monkeys didn’t make a sound. They were used to visitors, and on ... |
| 09.01.2012 | BioLeap shares drug discovery technology in research collaboration | The company was started in 2004 and raised $5 million in a series A financing round led by Quaker Partners and Adams Capital Management in 2010. It has signed collaborative agreements with companies such as GlaxoSmithKline (NYSE:GSK) and th... |
| - | BioLeap shares drug discovery technology in research collaboration | BioLeap, a developer of drug discovery technology, is sharing its molecule building technology in a research collaboration with Tokyo-based Kyorin Pharmaceuticals. BioLeap’s technology takes a different approach to traditional drug developm... |